Yahoo
NasdaqGS - Nasdaq Real Time Price USD

CytomX Therapeutics, Inc. (CTMX)

2.3400 +0.0500 (+2.18%)
At close: October 30 at 4:00:01 PM EDT
2.3800 +0.0400 (+1.71%)
After hours: October 30 at 5:42:51 PM EDT
Trade CTMX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
18,303
76,201
138,103
101,214
53,163
Operating Expense
105,456
98,565
113,108
107,698
154,498
Operating Income
-87,153
-22,364
24,995
-6,484
-101,335
Net Non Operating Interest Income Expense
7,720
5,206
7,136
9,837
1,678
Other Income Expense
11
28
-38
-30
340
Pretax Income
-79,422
-17,130
32,093
3,323
-99,317
Tax Provision
231
238
224
3,892
0
Net Income Common Stockholders
-79,653
-17,368
31,869
-569
-99,317
Diluted NI Available to Com Stockholders
-79,653
-17,368
31,869
-569
-99,317
Basic EPS
-0.57
-0.15
0.38
-0.01
-1.51
Diluted EPS
-0.57
-0.15
0.38
-0.01
-1.51
Basic Average Shares
182,939.3420
137,935.8730
84,439.3030
73,808.2370
65,739.8440
Diluted Average Shares
182,939.3420
137,935.8730
84,745.1160
73,808.2370
65,739.8440
Total Operating Income as Reported
-87,153
-22,364
24,995
-6,484
-101,335
Total Expenses
105,456
98,565
113,108
107,698
154,498
Net Income from Continuing & Discontinued Operation
-79,653
-17,368
31,869
-569
-99,317
Normalized Income
-79,653
-17,368
31,869
-569
-99,317
Interest Income
7,720
5,206
7,136
9,837
1,678
Net Interest Income
7,720
5,206
7,136
9,837
1,678
EBIT
-87,153
-22,364
24,995
-6,484
-101,335
EBITDA
-86,211
-20,988
26,763
-4,309
-98,892
Reconciled Depreciation
942
1,376
1,768
2,175
2,443
Net Income from Continuing Operation Net Minority Interest
-79,653
-17,368
31,869
-569
-99,317
Normalized EBITDA
-86,211
-20,988
26,763
-4,309
-98,892
Tax Rate for Calcs
0.0004
0.0002
0
0.0002
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 10/8/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: